Speaker illustration

Mrs Florence Petit Dop

International Research Institute Servier (IRIS), Suresnes (France)

Favourable safety profile of S62798, a potent TAFIa (activated thrombin-activatable fibrinolysis inhibitor) inhibitor, in first-in-man study in healthy subjects

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Clinical

Session: Advances in Chronic Thromboembolic Pulmonary Hypertension

Thumbnail

This platform is supported by

logo Novo Nordisk